학술논문
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
Document Type
Article
Author
Jenkin, Daniel ; Ritchie, Adam J ; Aboagye, Jeremy; Fedosyuk, Sofiya; Thorley, Luke; Provstgaad-Morys, Samuel; Sanders, Helen; Bellamy, Duncan; Makinson, Rebecca; Xiang, Zhi Quan; Bolam, Emma; Tarrant, Richard; Ramos Lopez, Fernando; Platt, Abigail; Poulton, Ian; Green, Catherine; Ertl, Hildegund C J; Ewer, Katie J; Douglas, Alexander D
Source
In The Lancet Microbe September 2022 3(9):e663-e671
Subject
Language
ISSN
2666-5247